ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1285

Association of Frailty with Disability Is Not Attenuated by Lean Body Mass in Women with SLE

Sarah Lieber1, Patricia Katz2, Joshua Baker3, Deanna Jannat-Khah4, Dina Sheira1 and Lisa Mandl1, 1Hospital for Special Surgery, New York, NY, 2University of California, San Francisco, Novato, CA, 3University of Pennsylvania, Philadelphia, PA, 4Hospital for Special Surgery, New York City, NY

Meeting: ACR Convergence 2020

Keywords: body composition, Disability, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Comorbidities

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Frailty has been associated with disability and mortality in SLE. Whether this association is confounded by sarcopenia, a degenerative loss of muscle mass and quality typically associated with aging, has not been explored. This aim of this study is to evaluate the cross-sectional association of frailty with self-reported disability, adjusting for lean body mass.

Methods: Adult women with validated SLE and mild/moderate disease were recruited from 2 centers. Frailty and pre-frailty were measured according to Fried frailty criteria (unintended weight loss, weakness, slow gait, poor endurance, inactivity) and disability according to Valued Life Activities. Dual energy x-ray absorptiometry was used to compute sarcopenia based on 2 definitions (Foundation for the National Institutes of Health Biomarkers Consortium Sarcopenia Project [1] and European Working Group on Sarcopenia in Older People 2 [2]) incorporating measures of muscle strength and quantity. Associations between frailty and disability were determined using univariate and multivariate linear regression models adjusted for age, race/ethnicity, SLE duration, current steroid use, high-sensitivity CRP (hsCRP), and 2 measures of lean body mass, appendicular lean mass index (ALMI) and adiposity-adjusted ALMI Z-score, reflecting the number of standard deviations from average for a given level of adiposity using National Health and Nutrition Examination Survey reference ranges.

Results: In the combined cohort of 210 women with SLE, 20% of participants were frail and 58% were pre-frail (Table 1). Frail women were significantly older (p=0.05), with lesser educational attainment (p=0.02), greater disease activity (p< 0.001), more damage (p=0.04 for SLICC/ACR Damage Index; p< 0.001 for Brief Index of Lupus Damage), higher hsCRP (p=0.01), and more frequent steroid use (p=0.01) and cigarette smoking (p=0.02). Sarcopenia was more prevalent among frail women with SLE as compared to pre-frail and non-frail women according to both definitions (p< 0.001). There was a significant dose-dependent association between frailty and pre-frailty and disability (p< 0.001), which was not attenuated after adjustment for multiple confounders and either measure of lean body mass (Table 2).

Conclusion:

Frailty was significantly associated with disability. Sarcopenia was more common among frail than pre-frail and non-frail women with SLE. The association of frailty with disability was not attenuated by multiple covariates, including lean body mass. These data suggest that frailty is a distinct phenotype not fully described by direct measures of low muscle mass. Further study is needed to determine the relative contributions of frailty and sarcopenia to other adverse health outcomes in SLE.

References:

1. Studenski et al. J Gerontol A Biol Sci Med Sci 2014;69:547-8.
2. Cruz-Jentoft et al. Age Ageing 2019;48:16-31.

Table 1

Table 2


Disclosure: S. Lieber, None; P. Katz, None; J. Baker, None; D. Jannat-Khah, Astrazeneca, 1, Cytodyn, 1, Walgreens Boots Alliance, 1; D. Sheira, None; L. Mandl, Annals of Internal Medicine, 9, UpToDate, 7, Regeneron, 2.

To cite this abstract in AMA style:

Lieber S, Katz P, Baker J, Jannat-Khah D, Sheira D, Mandl L. Association of Frailty with Disability Is Not Attenuated by Lean Body Mass in Women with SLE [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/association-of-frailty-with-disability-is-not-attenuated-by-lean-body-mass-in-women-with-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-frailty-with-disability-is-not-attenuated-by-lean-body-mass-in-women-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology